ClinicalTrials.Veeva
Menu

Find clinical trials for Glioblastoma (GBM) in Orlando, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Recurrence
Brain Cancer
Glioma
Astrocytoma
Cancer
Gliosarcoma

Glioblastoma (GBM) trials near Orlando, FL, USA:

Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)

therapy alone as a treatment for newly diagnosed MGMT unmethylated glioblastoma patients. The patients' own cancer cells collected after sur...

Enrolling
Glioblastoma Multiforme of Brain
Biological: TVI-Brain-1
Procedure: Standard of Care

Phase 2, Phase 3

TVAX Biomedical

Orlando, Florida, United States and 4 other locations

This is an open-label, monotherapy study of pemigatinib in participants with recurrent glioblastoma (GBM) or other recurrent glioma...

Active, not recruiting
Glioblastoma
Adult-type Diffuse Gliomas
Drug: Pemigatinib

Phase 2

Incyte
Incyte

Orlando, Florida, United States and 80 other locations

This is a Phase 1 dose-escalation study of PRT3645, a Cyclin-dependent Kinase 4/6 (CDK4/6) inhibitor, in patients with advanced or metastatic solid t...

Active, not recruiting
Glioblastoma
Endometrial Cancer
Drug: PRT3645

Phase 1

Prelude Therapeutics

Celebration, Florida, United States and 12 other locations

OKN-007 combined with temozolomide(TMZ) in patients with recurrent glioblastoma(GBM). All patients will have been previously treate...

Active, not recruiting
Brain Glioblastoma
Recurrent Malignant Glioma
Drug: Temozolomide (TMZ)
Drug: OKN-007

Phase 2

Oblato

Orlando, Florida, United States and 12 other locations

To test the effectiveness and safety of Optune® given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM...

Active, not recruiting
Glioblastoma Multiforme
Device: Optune®
NovoCure
NovoCure

Orlando, Florida, United States and 132 other locations

(TNBC), ovarian cancer, gastric cancer, colorectal cancer (CRC), glioblastoma (GBM), biliary tract cancers (BTC), or pancreatic can...

Active, not recruiting
Glioblastoma
Gastric Cancer
Biological: Pembrolizumab
Drug: Lenvatinib

Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Orlando, Florida, United States and 87 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems